Azithromycin for Meningococcal Carriage

Completed · Phase 2

Conditions studied: Meningococcal Infections

In brief

The purpose of this study is to determine the effectiveness of azithromycin in the eradication of nasopharyngeal carriage of N. meningitidis

Key facts

Study ID

NCT06618534

Run by

Emory University

People needed

764

Starts

2024-11-12

Expected to finish

2026-04-29

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older, up to 25. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Able to provide their own informed consent and understand study procedures
• Undergraduate and graduate students attending Emory University affiliated campuses who reside in university affiliated housing (for undergraduate/graduate) or in off-campus housing (undergraduates).

You may not qualify if…

• University faculty and staff
• Currently pregnant or breast feeding
• History of immediate or moderate-to-severe allergic reactions to azithromycin
• Individuals who have taken systemic antibiotics for any reason in the 30 days prior to enrollment
• Individuals with any symptoms of acute illness at the time of screening

Where it is running

• Hope Clinic of the Emory Vaccine Center — Decatur, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.